B S, Fairfield University, 1981 - 1985
FA, Mount Sinai School Of Medicine, Thoracic Surgery, 2017 - 2018
FELLOW, Cornell New York Hospital, Thoracic Surgery, 1996 - 1998
FELLOW, National Heart, Lung & Blood Institute, Research Fellow, 1992 - 1994
INTERN, Hartford Hospital, General Surgery, 1989 - 1990
MBA, University Of Massachusetts, 2015 - 2017
MD, University Of Connecticut School Of Medicine, 1985 - 1989
RES, University Of Connecticut Health Center, General Surgery, 1990 - 1996
- Board Certifications
American Board Of Surgery - Certified, 1997
American Board Of Thoracic Surgery - Certified, 1999
Get to Know Me
What are some of the specific conditions you treat?
Lung cancer, esophageal cancer, mediastinal tumors, thymoma, barrett's esophagus, myasthenia gravis, hyperhidrosis, gastroesophageal reflux, achalasia, zenker's diverticulum, tracheal stenosis, tracheal tumors, cricopharyngeal dysphagia, pleural tumors, mesothelioma.
What techniques or procedures do you use in your practice?
Minimally invasive lung and esophageal cancer surgery, VATS lobectomy, thoracoscopic sympathectomy, endobronchial ultrasound, navigational bronchoscopy, endoscopic submucosal resection for early esophageal tumors, radiofrequency ablation for barrett's esophagus, laparoscopic hiatal hernia repair, pneumonectomy, laparoscopic heller myotomy, laparoscopic fundoplication, gastrectomy.
Describe some of your professional highlights.
A dedicated thoracic oncologic surgeon trained at Memorial Sloan-Kettering Cancer Center that also specializes in diseases of the esophagus. An active researcher with over 90 peer-reviewed publications and over 40 scientific presentations at national and international meetings. Current President of the International Thymic Malignancy Interest Group, a professional society of over 600 clinicians and researchers around the world dedicated to the study of thymic neoplasms.
Publications & Research
Analysis of Gene Expression in Peripheral Blood Mononuclear Cells in Lung Cancer
A study aimed at isolating and characterizing biomarkers for lung cancer
The Early Lung Cancer Action Program
An international consortium aimed at collecting data on the utility of low dose CT scan for screening in lung cancer
Outlier Analysis of cases with exceptional characteristics in the International Thymic Malignancy Interest Group Database
A study of cases with outlier characteristics aimed at identifying unifying characteristics of selected patients with thymic neoplasms
A Randomized Trial of Lobectomy versus Sublobar Resection for Small Peripheral Non-small Cell Lung Cancer
Adjuvant Lung Cancer Enrichment marker Identification and Sequencing Trial (ALCHEMIST)
A clinical trial aimed at determining if lung cancers express certain markers that can then be targeted with specific targeted therapies.
A Phase III, Open-label, Randomized Study to Investigate the Efficacy and Safety of MPDL3280A (anti-PD1 antibody) Compared with Best Supportive Care Following Adjuvant Cisplatin-based Chemotherapy in PDL1-selected Patients with Completely Resected Stage 1
A clinical trial investigating whether a novel antibody that enhances antitumor immunity will be useful in treating patients with lung cancer.
A multicenter, Expanded Access Program for the Treatment of patients with Advanced/Metastatic EGFR T790M Mutation-positive Non-small Cell Lung Cancer who have Received Prior EGFR TKI Therapy
A clinical trial aimed at determining if a novel EGFR inhibitor will be useful for those patients who have mutated lung cancer that have progressed through first line anti EGFR therapy.
A Randomized Comparison of Adctive Suction vs Passive Drainage and Regulated and unregulated Pleural Pressure after Anatomic Lung Resection
A clinical trial aimed at determining the best method for draining the chest following lung resection
Valley Medical Group providers accept the following plans.
Patient Ratings & Comments
Comments are gathered from our patient satisfaction surveys.